Quality of life improvement after one year follow up in patients with refractory anginapectoris treated with enhanced external counter pulsation
Heider Hemeed Abbas , Ali Yahya Abdullah, Ahmed N. Rajeeb, Khalid I. Amber, Ahmed Nasir Machchi
929
ABSTRACT
Background:: Refractory
angina is usually portrayed as a prolonged state (equal or more than 3 months
in duration) considered by angina in the coronary vascular disorder setting,
which cannot be regulated by a consolidation of ideal therapeutic treatment,
surgical cardiac intervention, and where reversible cardiac ischemia has been
stated to be the reason for the manifestation clinically.
Aim: Safety use enhanced external counter pulsation in treating refractory
angina pectoris and short term outcome.
Method: Eighty eight (88) patients with refractory angina pectoris un respond to
treatment and/or intervention or unfit for intervention or surgery have been
enrolled in this prospective, single arm cohort clinical study, symptomatic
angina despite medication and/or intervention, for all ECG, echocardiography
study done to assess LV and valvular function, Doppler study for lower limb
artery to assess if there is peripheral vascular disease, abdominal ultrasound
done to exclude the presence of aortic abdominal aneurysm, then if patient
eligible for EECP inclusion criteria refer for EECP unit.
Results: Over 12 month’s period of the study, 88 persons were assessed including
26(30%) women and 62 (70%) men. The age range was 45 years to 80 years with the
mean age range 61 years (SD ± 8.2).
We found
statistically significant (p-value < 0.00001) change in symptom from CCS3
and CCS4 pre EECP to CCS1 and CCS2 post EECP. Also we observe that this change
in CCS after EECP persist to 6 month and to lesser in 1 year but generally
remain in CCS1 and CCS2 at end of 1 year which was also statistically
significant (p-value < 0.00001) and we observe that not response appear in
CCS4 and CCS3 patients where there improvement persist to the end of year.
Conclusion: EECP appear as safe effective therapy in selective patient with
refractory angina not respond to medical and unfit for intervention or surgery.
Response to EECP in well selected patient persist for 1 year
Keywords:
EECP, Refractory angina pectoris, Quality of life.
ABSTRACT
Background:: Refractory
angina is usually portrayed as a prolonged state (equal or more than 3 months
in duration) considered by angina in the coronary vascular disorder setting,
which cannot be regulated by a consolidation of ideal therapeutic treatment,
surgical cardiac intervention, and where reversible cardiac ischemia has been
stated to be the reason for the manifestation clinically.
Aim: Safety use enhanced external counter pulsation in treating refractory
angina pectoris and short term outcome.
Method: Eighty eight (88) patients with refractory angina pectoris un respond to
treatment and/or intervention or unfit for intervention or surgery have been
enrolled in this prospective, single arm cohort clinical study, symptomatic
angina despite medication and/or intervention, for all ECG, echocardiography
study done to assess LV and valvular function, Doppler study for lower limb
artery to assess if there is peripheral vascular disease, abdominal ultrasound
done to exclude the presence of aortic abdominal aneurysm, then if patient
eligible for EECP inclusion criteria refer for EECP unit.
Results: Over 12 month’s period of the study, 88 persons were assessed including
26(30%) women and 62 (70%) men. The age range was 45 years to 80 years with the
mean age range 61 years (SD ± 8.2).
We found
statistically significant (p-value < 0.00001) change in symptom from CCS3
and CCS4 pre EECP to CCS1 and CCS2 post EECP. Also we observe that this change
in CCS after EECP persist to 6 month and to lesser in 1 year but generally
remain in CCS1 and CCS2 at end of 1 year which was also statistically
significant (p-value < 0.00001) and we observe that not response appear in
CCS4 and CCS3 patients where there improvement persist to the end of year.
Conclusion: EECP appear as safe effective therapy in selective patient with
refractory angina not respond to medical and unfit for intervention or surgery.
Response to EECP in well selected patient persist for 1 year
Keywords:
EECP, Refractory angina pectoris, Quality of life.